Susan Salka - AMN Healthcare CEO
| AMN Stock | USD 24.07 0.51 2.07% |
CEO
Ms. Susan R. Salka is President, Chief Executive Officer, Director of AMN Healthcare Services, Inc. Ms. Salka has served as our President since May 2003 and our CEO since May 2005. The Board has concluded that Ms. Salka is qualified to serve on the Board because she has nearly three decades of healthcare services industry experience, including 27 years of experience with us in various roles, including Chief Financial Officer and Chief Operating Officer. During her service to the Company, she has helped grow our business both organically and through acquisitions into the national industry leader we are today. Prior to joining us, Ms. Salka worked at BioVest Partners, a VC firm, and at Hybritech, a subsidiary of Eli Lilly Co., which Beckman Coulter later acquired. Ms. Salka is recognized as a leader in corporate governance and currently serves as a director of McKesson Corporationration, including as Chairperson of its Corporationrationrate Governance Committee and as a member of its Compensation Committee. She also serves on the Board of San Diego State University Campanile Foundation. Ms. Salka served on the Board and the Audit Committee of Beckman Coulter from 2007 until 2011, when Danaher Corporation acquired it. Additionally, she served on the Board of Playtex Products, Inc. from 2001 until Energizer Holdings acquired it in October 2007. since 2005.
| Age | 56 |
| Tenure | 20 years |
| Address | 2999 Olympus Boulevard, Dallas, TX, United States, 75019 |
| Phone | 866 871 8519 |
| Web | https://www.amnhealthcare.com |
Susan Salka Latest Insider Activity
Tracking and analyzing the buying and selling activities of Susan Salka against AMN Healthcare stock is an integral part of due diligence when investing in AMN Healthcare. Susan Salka insider activity provides valuable insight into whether AMN Healthcare is net buyers or sellers over its current business cycle. Note, AMN Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell AMN Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Susan Salka over six months ago Disposition of tradable shares by Susan Salka of McKesson at 554.61 subject to Rule 16b-3 |
AMN Healthcare Management Efficiency
The company has Return on Asset of 0.028 % which means that on every $100 spent on assets, it made $0.028 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1912) %, meaning that it generated no profit with money invested by stockholders. AMN Healthcare's management efficiency ratios could be used to measure how well AMN Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. As of the 20th of March 2025, Return On Tangible Assets is likely to grow to -0.12. In addition to that, Return On Capital Employed is likely to grow to -0.05. At this time, AMN Healthcare's Non Current Assets Total are very stable compared to the past year. As of the 20th of March 2025, Non Currrent Assets Other is likely to grow to about 346.4 M, while Total Assets are likely to drop about 1.2 B.Similar Executives
| Found 10 records | CEO Age | ||
| Christopher Christensen | The Ensign Group | 56 | |
| April Anthony | Encompass Health Corp | 53 | |
| John Rademacher | Option Care Health | 58 | |
| Mark Tarr | Encompass Health Corp | 63 | |
| Patrick Blair | InnovAge Holding Corp | 54 | |
| Richard Ashworth | Amedisys | 50 | |
| Dirk CPA | Addus HomeCare | 69 | |
| Dirk Allison | Addus HomeCare | 68 | |
| Paul Kusserow | Amedisys | 63 | |
| David Chernow | Select Medical Holdings | 68 | |
Management Performance
| Return On Equity | -0.19 | ||||
| Return On Asset | 0.028 |
AMN Healthcare Services Leadership Team
Elected by the shareholders, the AMN Healthcare's board of directors comprises two types of representatives: AMN Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AMN. The board's role is to monitor AMN Healthcare's management team and ensure that shareholders' interests are well served. AMN Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AMN Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| R Harris, Independent Director | ||
| Cole Edmonson, Chief Experience and Clinical Officer | ||
| Nishan Sivathasan, Division Solutions | ||
| Mark Foletta, Independent Director | ||
| Landry Seedig, Group President and Chief Operating Officer, Nurse and Allied Solutions | ||
| Julie Fletcher, Chief Officer | ||
| Randle Reece, IR Contact Officer | ||
| Kelly Rakowski, Group President and Chief Operating Officer, Strategic Talent Solutions | ||
| Jeffrey Knudson, Chief Financial Officer, Chief Accounting Officer | ||
| Meredith Lapointe, Chief Officer | ||
| Patrick McCall, Chief Officer | ||
| Brian Scott, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| Teri Fontenot, Independent Director | ||
| Whitney Laughlin, Corporate Officer | ||
| Christopher Schwartz, Principal Financial Officer | ||
| Denise Jackson, Senior Vice President, General Counsel, Secretary | ||
| Michael Johns, Independent Director | ||
| Julie Purinton, Division Nurse | ||
| Susan Salka, CEO and President Director and Member of Executive Committee | ||
| James Taylor, Group President and Chief Operating Officer for Physician & Leadership Solutions | ||
| Kimberly Martini, Division Solutions | ||
| Jorge Caballero, Independent Director | ||
| Martha Marsh, Independent Director | ||
| Kerry Perez, Chief Officer | ||
| Mark Hagan, Chief Information Office and Digital Officer, Executive Officer | ||
| Robin Johnson, Group Solutions | ||
| Sylvia TrentAdams, Independent Director | ||
| Douglas Wheat, Independent Chairman of the Board | ||
| Caroline Grace, CEO President | ||
| Carolyn Kenny, Chief Officer | ||
| Tomya Watt, Chief Officer | ||
| Jeff Decker, Division Solutions | ||
| Daphne Jones, Independent Director |
AMN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AMN Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.19 | ||||
| Return On Asset | 0.028 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.03 B | ||||
| Shares Outstanding | 38.2 M | ||||
| Shares Owned By Insiders | 0.99 % | ||||
| Shares Owned By Institutions | 99.01 % | ||||
| Number Of Shares Shorted | 3.82 M | ||||
| Price To Earning | 12.02 X |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMN Healthcare Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AMN Healthcare. If investors know AMN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AMN Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share (3.85) | Revenue Per Share | Quarterly Revenue Growth (0.10) | Return On Assets |
The market value of AMN Healthcare Services is measured differently than its book value, which is the value of AMN that is recorded on the company's balance sheet. Investors also form their own opinion of AMN Healthcare's value that differs from its market value or its book value, called intrinsic value, which is AMN Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AMN Healthcare's market value can be influenced by many factors that don't directly affect AMN Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AMN Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if AMN Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AMN Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.